8.2550
29-نوفمبر-24 13:45:00
15 متأخرة بدقائق
الأسهم
-0.1350
-1.61%
نطاق اليوم
8.0700 - 8.3900
ISIN
BE0974358906
المصدر
NASDAQ
Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
09 فبراير 2021 01:00:13 بحسب Nasdaq GlobeNewswire
Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)
02 فبراير 2021 00:56:05 بحسب Nasdaq GlobeNewswire
Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
26 يناير 2021 01:02:09 بحسب Nasdaq GlobeNewswire
First US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)
05 يناير 2021 01:39:42 بحسب Nasdaq GlobeNewswire